Cerebrovascular Accident Clinical Trial
Official title:
Lever Actuated Rehabilitation of the Arm Using Wheelchair Propulsion and Computer Gaming
Verified date | July 2020 |
Source | University of California, Irvine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will test the effectiveness of a new lever drive wheelchair, LARA - Lever Actuated
Resonance Assistance. LARA facilitates patients in performing a high amount of practice using
their moderate to severely impaired upper extremity after stroke.
Investigators will recruit 44 subjects with subacute strokes to participate in the study
through the acute rehabilitation unit of the UC Irvine Douglas Hospital. Study participants
will be randomized into 2 groups: LARA therapy group or standard therapy group. The LARA
therapy group will use LARA to propel themselves to therapy appointments in the unit and to
play video games with the affected upper extremity for 30 mins / day. The standard therapy
group will use a standard wheelchair to propel themselves using their unaffected upper and
lower extremities. They will be asked to perform a matched duration of standard arm exercises
for 30 mins/ day. This program of standard arm exercises was developed by an OT at the
Rehabilitation Institute of Chicago which consists of graded-difficulty table-supported
exercises.
This study will have 3 assessment visits: baseline, 3 weeks after therapy or upon discharge
from the acute rehabilitation unit if sooner, and a 3-month follow up.
Status | Completed |
Enrollment | 23 |
Est. completion date | January 10, 2019 |
Est. primary completion date | January 10, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: 1. Age = 18 years at the time of enrollment 2. Stroke onset 1-4 weeks prior to study enrollment 3. Arm motor FM score of < 30 (out of 66) at Baseline Visit 4. Absence of moderate to severe shoulder pain ( Score <3 on the 10 point visual analog pain scale) 5. Any deficit in vision, alertness, language, attention, or other cognitive functions that interfere with playing the LARA games Exclusion Criteria: 1. Age >80 years at the time of enrollment 2. Severe tone in the affected upper extremities (Score = 4 on the Modified Ashworth Spasticity Scale) 3. Severe language problem that would prevent participants from properly understanding instructions 4. Severe reduced level of consciousness 5. Severe aphasia (score of 3 on the NIH stroke scale (question 9)) 6. Severe loss of sensation in stroke-affected upper extremities (Score < 1 on the Nottingham sensory assessment) 7. Currently pregnant 8. Difficulty in understanding or complying with the instructions given by the experimenter 9. Inability to perform the experimental task that will be studied |
Country | Name | City | State |
---|---|---|---|
United States | University of California, Irvine | Irvine | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Irvine |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fugl-Meyer (FM) Motor Assessment of the Upper Extremity | We measure the change of the Fugl-Meyer Motor Assessment scores from the baseline evaluation to the 3-month follow up evaluation after the end of intervention. Fugl-Meyer is a 66-point scale measuring the movement pattern of the upper extremities. For the study, we analyze the total score only. The higher scores indicate a better outcome. | Baseline, Post-intervention evaluation at 3 weeks, and 3-month evaluation after the end of intervention | |
Secondary | Modified Ashworth Spasticity Scale | We measure the spasticity of the upper extremity at baseline, post-intervention, and at the 3-month follow up evaluation. Spasticity is described as the resistance to passive movement. Participants are asked to relax and evaluators assess muscle resistance to passive movement at one joint at a time: Shoulder, Elbow, Wrist, and Fingers. The evaluator will then grade the resistance on a 6-point scale for each joint. Higher scores indicate more rigid movement or more muscle tone resistance. The minimum score is zero and the maximum score is 4. For this study, we combine all subscores from each joint to compute a total spasticity score. | Baseline, Post-intervention evaluation at 3 weeks, and 3-months after the end of intervention | |
Secondary | Timed 10-meter Walk | We measure the time one takes to complete a 10-meter walk at baseline evaluation, the post-intervention evaluation, and the 3-month follow up evaluation. Participants are instructed to walk at a distance of 10-meter over a level surface with 2 meters for acceleration and 2 meters for deceleration. Participants are instructed to walk at their comfortable or normal speed over the entire distance. Participants are timed once the first foot passes the acceleration path; the time is stopped once the first foot enters the deceleration path. The lower scores indicate a better outcome. | Baseline, Post-intervention evaluation at 3 weeks, and 3-months after the end of intervention | |
Secondary | Box and Blocks Test | We measured the Box and Blocks Test scores at baseline evaluation, the post-intervention, and at the 3-month follow up evaluation. Participants are instructed to move as many blocks as possible, one at a time, from one compartment in a box to a second compartment over a divider for a period of 60 seconds; each block that is moved is counted, and multiple blocks moved at the same time are counted are counted as a single block. The higher scores indicate a better outcome. | Baseline, Post-intervention evaluation at 3 weeks, and 3-months after the end of intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05477238 -
Oxygen Consumption in Post-stroke Patients During Various Walking Activities Compared to Healthy Controls
|
N/A | |
Completed |
NCT00046293 -
ReoPro and Retavase to Treat Acute Stroke
|
Phase 2 | |
Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
Completed |
NCT01116544 -
Treatment of Chronic Stroke With AMES + EMG Biofeedback
|
N/A | |
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Active, not recruiting |
NCT02563886 -
Electrically Assisted Movement Therapy
|
N/A | |
Recruiting |
NCT02446730 -
Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome
|
Phase 4 | |
Completed |
NCT02141932 -
Pocket-size Cardiovascular Ultrasound in Stroke
|
N/A | |
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Recruiting |
NCT02557737 -
Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper Extremities
|
Phase 3 | |
Recruiting |
NCT01769326 -
Influence of Timing on Motor Learning
|
N/A | |
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Completed |
NCT01656876 -
The Effects of Mirror Therapy on Upper Extremity in Stroke Patients
|
N/A | |
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT01423201 -
Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
|
||
Withdrawn |
NCT00573092 -
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
|
N/A | |
Completed |
NCT00542256 -
tDCS and Physical Therapy in Stroke
|
N/A | |
Completed |
NCT00377689 -
Evaluation of an Intervention Program Targeted at Improving Balance and Functional Skills After Stroke
|
Phase 2 | |
Recruiting |
NCT00166751 -
Sonographic Assessment of Laryngeal Elevation
|
N/A | |
Completed |
NCT00125619 -
Internally Versus Externally Guided Body Weight-Supported Treadmill Training (BWSTT) for Locomotor Recovery Post-stroke
|
N/A |